Literature DB >> 30012291

Risk Factors, Disease Associations, and Dupuytren Diathesis.

Sandip Hindocha1.   

Abstract

Dupuytren disease (DD) is a benign, fibroproliferative disease of unknown cause. The disease predominantly affects the palms of the hands, causing permanent digital contracture of affected digits. DD is a late-onset disease and is often progressive, irreversible, and bilateral. The disease has a significant impact on the health care economy. The mainstay of treatment of DD is surgical excision of diseased palmar fascia. There is evidence of genetic susceptibility. This article introduces the epidemiology of DD and examines the Dupuytren diathesis to highlight the importance of identifying clinical severity in relation to patient counseling and recurrence risk following treatment. Crown
Copyright © 2018. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diathesis; Dupuytren disease; Epidemiology; Inheritance; Risk factors

Mesh:

Substances:

Year:  2018        PMID: 30012291     DOI: 10.1016/j.hcl.2018.03.002

Source DB:  PubMed          Journal:  Hand Clin        ISSN: 0749-0712            Impact factor:   1.907


  6 in total

Review 1.  Dupuytren's Disease: An Outcomes-Focused Update.

Authors:  Yasser H Almadani; Joshua Vorstenbosch; Johnny Ionut Efanov; Liqin Xu
Journal:  Semin Plast Surg       Date:  2021-07-06       Impact factor: 2.195

2.  The Role of Functional Polymorphisms in the Extracellular Matrix Modulation-Related Genes on Dupuytren's Contracture.

Authors:  Gediminas Samulenas; Ruta Insodaite; Edita Kunceviciene; Roberta Poceviciute; Lorena Masionyte; Urte Zitkeviciute; Loreta Pilipaityte; Alina Smalinskiene
Journal:  Genes (Basel)       Date:  2022-04-23       Impact factor: 4.141

3.  Dupuytren's Contracture: Incidence of Injury-Induced Cases and Specific Clinical Expression.

Authors:  Gediminas Samulėnas; Rytis Rimdeika; Kęstutis Braziulis; Mantas Fomkinas; Rokas Paškevičius
Journal:  Medicina (Kaunas)       Date:  2020-06-30       Impact factor: 2.430

4.  Report on the Evidence-Based Practice Committee's Survey on Dupuytren Disease.

Authors:  Farhan Ahmad; Noah Raizman; Aviram M Giladi; Anil Akoon; M Daniel Wongworawat; Robert W Wysocki
Journal:  J Hand Surg Glob Online       Date:  2021-09-15

5.  Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis.

Authors:  Vladimir Zah; Jovana Pelivanovic; Simona Tatovic; Djurdja Vukicevic; Martina Imro; Jane Ruby; David Hurley
Journal:  Clinicoecon Outcomes Res       Date:  2020-11-04

6.  Evaluation of WNT Signaling Pathway Gene Variants WNT7B rs6519955, SFRP4 rs17171229 and RSPO2 rs611744 in Patients with Dupuytren's Contracture.

Authors:  Gediminas Samulėnas; Alina Smalinskienė; Rytis Rimdeika; Kęstutis Braziulis; Mantas Fomkinas; Rokas Paškevičius
Journal:  Genes (Basel)       Date:  2021-08-24       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.